The GPVI – Fc Fusion Protein Revacept Reduces Thrombus Formation and Improves Vascular Dysfunction in Atherosclerosis without Any Impact on Bleeding Times

• Martin Ungerer ,

  Contributed equally to this work with: Martin Ungerer, Zhongmin Li

  Affiliation advanceCOR GmbH (formerly, Procorde GmbH), Martinsried, Germany

  ⨯
• Zhongmin Li ,

  Contributed equally to this work with: Martin Ungerer, Zhongmin Li

  Affiliation advanceCOR GmbH (formerly, Procorde GmbH), Martinsried, Germany

  ⨯
• Christine Baumgartner,

  Current address: Centre of Preclinical Research, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

  Affiliation advanceCOR GmbH (formerly, Procorde GmbH), Martinsried, Germany

  ⨯
• Silvia Goebel,

  Affiliation advanceCOR GmbH (formerly, Procorde GmbH), Martinsried, Germany

  ⨯
• Jasmin Vogelmann,

  Affiliation advanceCOR GmbH (formerly, Procorde GmbH), Martinsried, Germany

  ⨯
• Hans-Peter Holthoff,

  Affiliation advanceCOR GmbH (formerly, Procorde GmbH), Martinsried, Germany

  ⨯
• Meinrad Gawaz ,

  * E-mail: muench@advanceCOR.com (GM); meinrad.gawaz@med.uni-tuebingen.de (MG)

  Affiliation Medizinische Klinik III, Kardiologie und Kreislauferkrankungen, Eberhard Karls Universität Tübingen, Tübingen, Germany

  ⨯
• Götz Münch

  * E-mail: muench@advanceCOR.com (GM); meinrad.gawaz@med.uni-tuebingen.de (MG)

  Affiliation advanceCOR GmbH (formerly, Procorde GmbH), Martinsried, Germany

  ⨯